Journal article
Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban”
Authors
Turpie AGG
Journal
The Journal of Clinical Pharmacology, Vol. 51, No. 7, pp. 1122–1123
Publisher
Wiley
Publication Date
July 1, 2011
DOI
10.1177/0091270010377503
ISSN
0091-2700